Cirrus Therapeutics
Cirrus Therapeutics is a Biotechnology Research firm diganosing and treating eye diseases affecting ocular immune system.
$14.7M Seed ·
Source: Dealroom
Funding history ↓Signals
Website registeredSep 29, 2021 (5 years old)
Funding rounds
Timeline
- Website created
Founders and team
AD
Andrew Dick FounderYC
Ying Chan Founder
Companies like Cirrus Therapeutics
CClaris Bio$118M Series B+ · Jul 2026
OOuro Medicines$120M Series A · Jan 2025
HHealome Therapeutics$2.69M Seed · Jul 2026
RRybodynSeed · Jul 2026
HHI-Bio$95M Series B+ · Jan 2024
MMatchpoint Therapeutics$150M Series B+ · Oct 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/cirrus-therapeutics (get a free API key).